CRISPR Therapeutics AG
NASDAQ: CRSP
$55.65
-$0.76 (-1.3%)
Closing price April 24, 2024
A couple of Cathie Wood's ARK Invest exchange-traded funds bought over 400,000 shares of CRISPR Therapeutics on October 10.
Published:
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
Published:
The WallStreetBets community has been a resounding force in the market since January causing many investors to reevaluate their positions. Here's a look going into this trading session.
Published:
The WallStreetBets community has been a resounding force in the market since January causing many investors to reevaluate their positions. Here's a look going into this trading session.
Published:
The WallStreetBets community has been a resounding force in the market since January causing many investors to reevaluate their positions. Here's a look going into this trading session.
Published:
The WallStreetBets community has been a resounding force in the market since January causing many investors to reevaluate their positions. Here's a look going into this trading session.
Published:
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
Published:
Monday’s top analyst upgrades and downgrades included Chipotle Mexican Grill, CRISPR, Hess Midstream, iMedia Brands, Kinder Morgan, Wendy’s and more.
Published:
Wednesday's top analyst upgrades and downgrades included AutoZone, Citrix Systems, Coinbase, CSX, Freeport-McMoRan, Intuitive Surgical, Morgan Stanley, Netflix and Oracle.
Published:
Last Updated:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Anthem, BioMarin, CRISPR, GE and more.
Published:
Thursday's top analyst upgrades and downgrades included Allstate, Bed Bath & Beyond, Simon Property, Spirit Airlines, Twitter and Under Armour.
Published:
Thursday's top analyst upgrades and downgrades included Best Buy, Booking, ConocoPhillips, CRISPR Therapeutics, Fisker, Halliburton, Lordstown Motors, RH, Tesla, Walt Disney and Zscaler.
Published:
Monday's top analyst upgrades and downgrades included Accenture, Boeing, CRISPR Therapeutics, DraftKings, Illumina, Lyft, McDonald's, Southwest Airlines and Teladoc Health.
Published:
Friday's top analyst upgrades and downgrades included Citrix Systems, CRISPR Therapeutics, Dunkin' Brands, Fastly, Intel, Mattel, PulteGroup, Sirius XM, Southwest Airlines Tesla and Under Armour.
Published:
Monday's top analyst upgrades and downgrades included American Express, AT&T, CRISPR Therapeutics, DocuSign, ONEOK, Regeneron Pharmaceuticals, Shopify and Tesla.
Published: